London, United Kingdom

Olivier Preham

This inventor holds 2 USPTO granted patents. Top assignee: Ucl Business Plc. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olivier Preham. Retrieved from https://idiyas.com/inventor/olivier-preham-z8cigah8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Olivier Preham: Innovator in Engineered Regulatory T Cells

Introduction

Olivier Preham is a notable inventor based in London, GB. He has made significant contributions to the field of biotechnology, particularly in the development of engineered regulatory T cells. With a total of 2 patents to his name, Preham is recognized for his innovative approaches to cellular engineering.

Latest Patents

His latest patents focus on the creation and application of engineered regulatory T cells. These advancements have the potential to revolutionize therapeutic strategies in immunology and cancer treatment.

Career Highlights

Olivier Preham is currently associated with UCL Business Plc, where he continues to push the boundaries of scientific research and innovation. His work is instrumental in bridging the gap between academic research and practical applications in the medical field.

Collaborations

Throughout his career, Preham has collaborated with esteemed colleagues such as Sharyn Thomas and Hans Stauss. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Olivier Preham stands out as a key figure in the field of engineered regulatory T cells, contributing valuable innovations that may lead to significant advancements in medical therapies. His work exemplifies the importance of collaboration and innovation in scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…